Nitric oxide-releasing mesalamine: Potential utility for treatment of inflammatory bowel disease

Digestive and Liver Disease

Volumn 35, Issue SUPPL. 2, 2003, Pages

  Wallace, J L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Aminosalicylic acid; Colitis; Inflammation; Inflammatory bowel disease

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; CYTOKINE; MESALAZINE; NCX 456; NITRIC OXIDE DONOR; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG; AMINOSALICYLIC ACID DERIVATIVE; DRUG DERIVATIVE; NAPROXEN; NITRIC OXIDE; NITRIC OXIDE NAPROXEN; NO MESALAMINE; NO-MESALAMINE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARDIOTOXICITY; COLITIS; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENCY; DRUG STRUCTURE; DRUG TISSUE LEVEL; ENTERITIS; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATORY INFILTRATE; NEPHROTOXICITY; NONHUMAN; ULCER HEALING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; LEUKOCYTE; RAT; REVIEW;

AMINOSALICYLIC ACIDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTES; MESALAMINE; NAPROXEN; NITRIC OXIDE; RATS;

EID: 14944378189     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00050-1     Document Type: Article

References (41)

1. Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 2000;118:S68-82.
2. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoidis, and proctitis. Gastroenterology 1987;92:1894-8.
3. Wallace JL, Miller MJS. Nitric oxide and mucosal defence: a little goes a long way. Gastroenterology 2000;119:512-20.
4. Elliott SN, McKnight W, Cirino G, Wallace JL. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995;109:524-30.
5. Wallace JL, Elliott SN, Del Soldato P, McKnight W, Sannicolo F, Cirino G. Gastrointestinal sparing anti-inflammatory drugs: the development of nitric oxide-releasing NSAIDs. Drug Dev Res 1997;42:144-9.
6. Wallace JL, Ignarro LJ, Fiorucci S. Potential cardioprotective actions of nitric oxide-releasing aspirin. Nature Reviews (Drug Discovery) 2002;1:375-82.
7. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 1994;107:173-9.
8. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol 1994;257:249-55.
9. Davies NM, Roseth AG, Appleyard CB, McKnight W, Del Soldato P, Calignano A, et al. NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther 1997;11:69-79.
10. Wallace JL, Muscará MN, McKnight W, Dicay M, Del Soldato P, Cirino G. In vivo anti-thrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016. Thromb Res 1999;93:43-50.
11. 4 synthesis. Gastroenterology 1992;102:18-27
12. Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest 1996;98:2076-85.
13. Kaufmann HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs quiescent inflammatory bowel disease. Ann Intern Med 1987;107:513-6
14. Bonner GF. Exacerbation of inflammatory bowel disease associated with use of celecoxib. Am J Gastroenterol 2001;96:1306-8.
15. Reuter BK, Cirino G, Wallace JL. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci 1994;55:PL1-8.
16. Cirino G, Wheeler-Jones CPD, Wallace JL, Del Soldato P, Baydoun AR. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivatives with gastrointestinal-sparing properties. Br J Pharmacol 1996;117:1421-6.
17. Grisham MB, Granger DN. 5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine. Dig Dis Sci 1989;34:573-8.
18. Sandhu IS, Grisham MB. Modulation of neutrophil function as a mode of therapy for gastrointestinal inflammation. In: Wallace JL, editor, Immunopharmacology of the gastrointestinal system, London Academic Press, 1993, pp. 51-67.
19. Lauritsen K, Laursen LS, Kjeldsen J, Bukhave K, Hansen TK, Rask-Madsen J. Effects of mesalazine on the formation of lipoxygenase and cyclooxygenase products. Adv Exp Med Biol 1995;371B:1301-6.
20. Harris DW, Smith PR, Swan CHJ. Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut 1978;19:875-7.
21. 2 release and its relation to disease activity; electrical potential difference, and treatment in ulcerative colitis. Gut 1980;21:591-6.
22. 4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986;91:837-44.
23. Eliakim R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. Gastroenterology 1988;95:1167-72.
24. Mahida YR, Lamming CE, Gallagher A, Hawthorne AB, Hawkey CJ. 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut 1991;32:50-4.
25. Miles AM, Grisham MB. Antioxidant properties of 5-aminosalicylic acid: potential mechanism for its protective effect in ulcerative colitis. Adv Exp Med Biol 1995;371B:1317-21.
26. Tamai H, Kachur JF, Grisham MB, Gaginella TS. Scavenging effect of 5-aminosalicylic acid on neutrophil-derived oxidants. Possible contribution to the mechanism of action in inflammatory bowel disease. Biochem Pharmacol 1991;41:1001-6.
27. Kvietys PR, Smith SM, Grisham MB, Manci EA. 5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. Gastroenterology 1988;94:733-8.
28. Grisham MB, Granger DN. Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 1988;33:S6-15.
29. Hernandez LA, Grisham MB, Twohig B, Arfors KE, Harlan JM, Granger DN. Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol 1987;253:H699-703.
30. Stenson WF, Mehta J, Spilberg I. Sulfasalazine inhibits the binding of formylmethionylleucylphenylalanine (FMLP) to its receptor on human neutrophils. Biochem Pharmacol 1982;33:407-12.
31. Grisham MB, Miles AM. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 1994;47:1897-902.
32. Sandoval M, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997;113:1480-8.
33. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258:G527-34.
34. Matsuda S, Uchikawa R, Yamada M, Arizono N. Cytokine mRNA expression profiles in rats infected with intestinal nematode Nippostrongylus brasiliensis. Infect Immun 1995;63:4653-60.
35. Wallace JL, Vergnolle N, Muscara MN, Asfaha S, Chapman K, McKnight W, et al. Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology 1999;117:557-66.
36. Wallace JL, Muscara MN, McKnight W, Dicay M, Del Soldato P, Cirino G. In vivo anti-thrombotic effects of NCX-4016: a nitric oxide-releasing aspirin derivative. Thromb Res 1999;93:43-50.
37. Beck PL, Wallace JL. Cytokines in inflammatory bowel disease. Med Inflamm 1997;6:95-103.
38. Fiorucci S, Santucci L, Federici B, Antonelli E, Distrutti E, Morelli O, et al. Nitric oxide (NO)-releasing NSAIDs inhibit interleukin-1β converting enzyme (ICE)-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFα. Aliment Pharmacol Ther 1999;13:421-35.
39. Fiorucci S, Distrutti E, Ajuebor MN, Mencarelli A, Mannucci R, Palazzetti B, et al. NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines. Am J Physiol 2001;281:G654-65.
40. Muscara MN, McKnight W, Lovren F, Triggle CR, Cirino G, Wallace JL. Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats. Am J Physiol 2000;279:H528-35.
41. Fujihara CK, Malheiros DM, Donato JL, Poli A, De Nucci G, Zatz R. Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney. Am J Physiol 1998;274:F573-79.